ctDNA Molecular Response based on breast cancer driver mutations predicts progression in aromatase inhibitor-sensitive first line treatment of oestrogen receptor-positive (ER+) HER2-negative (HER2-) advanced breast cancerCaroline Bailleux,Thomas Bachelot,Francois-Clement Bidard,Anne-Claire Hardy-Bessard,Ivan Bieche,Anne Pradines,Florian Clatot,Thibault De La Motte Rouge,Jean-Luc Canon,Barbara Pistilli,Kyle Chang,Katie J. Quinn, Heather L. Gustafson,Florence Dalenc,Cyril Foa, Hanifa Ammarguellat,Chantal Bernard-Marty, Brigitte Lucas, Sophie Barthier, Fabrice Lorchel, Olivier Gisserot,Laurent Arnould,Marjorie Mauduit,Jerome Lemonnier,Frederique Berger,Suzette Delaloge,Fabrice AndreCANCER RESEARCH（2023）引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
